The Girard-Perregaux Laureato family celebrates a milestone with refreshed designs featuring ten intricate dial finishes and diverse steel-case options. This update enhances its versatility, blending luxurious craftsmanship with everyday practicality. The new colors and sizes cater to collectors and casual wearers alike, ensuring that the classic watch remains vibrant and contemporary.
Author: Yukiko Yamaguchi
The Age of Three Worlds: Europe’s Sovereignty, America’s Legacy, and China’s Ascent
France’s decision to trial its own AI-powered battlefield command system, Arcadia, during NATO exercises is a striking example of Europe’s growing determination to build alternatives to U.S. technology. Developed with French firms such as Mistral AI, Safran, Thales, and Airbus, Arcadia is being positioned as a European counterpart to Maven, the AI platform created by…
Financial Market: 11.13.25
The New York Times reported that newly released communications from Jeffrey Epstein revealed his disdain for Trump while hinting at the existence of potentially damaging information regarding Trump’s business empire. Epstein’s emails, characterized by typographical errors and revealing comments, indicated that he believed he had insider knowledge on Trump’s various real estate ventures. Notably, Epstein’s…
Financial Market: 11.12.25
One notable area of focus is the potential restrictions on proxy-advisory firms, with discussions reportedly taking place within the Trump administration. The proposed executive order could drastically alter how shareholder votes are approached, particularly impacting influential firms such as Institutional Shareholder Services and Glass Lewis. This could include banning shareholder recommendations and imposing limitations on…
Financial Markets: 11.11.25
Warren Buffett, the legendary investor and chairman of Berkshire Hathaway, has recently expressed his unwavering support for the company’s CEO-designate, Greg Abel. Buffett’s rare public remark emphasizes his confidence in Abel’s leadership capabilities, stating, “I can’t think of a CEO, a management consultant, an academic, a member of government – you name it – that…
Financial Markets: 11.7.25
In recent weeks, several significant developments have emerged in the financial landscape, offering a glimpse into both corporate governance and broader economic trends. From shareholder decisions at Tesla to troubling employment figures and shifts in consumer sentiment, these events highlight the complexities of today’s economic environment. At Tesla’s latest annual shareholder meeting, over 75% of…
Financial Markets: 11.6.25
Recent developments in the economic arena have triggered significant discussions, underscoring the complexities of policy, corporate strategies, and market dynamics. From tariffs and corporate relocations to soaring turkey prices, it is evident that the intersection of government decisions, corporate actions, and unforeseen circumstances shapes our economic realities. One glaring issue lies in the tariffs implemented…
Ulta Beauty Expands Footprint with Acquisition of Space NK
In a significant move within the beauty retail industry, Ulta Beauty has announced its acquisition of Space NK, a renowned British beauty retailer previously owned by Manzanita Capital. This acquisition was revealed on Thursday, although the financial terms of the deal remain undisclosed. With a robust presence consisting of 83 stores across the U.K. and…
UnitedHealth Group’s Significant Decline: The Medicare Advantage Dilemma
Last Thursday marked a tumultuous day for UnitedHealth Group as its shares plummeted over 22%, the most significant single-day drop since 1998. This drastic decline followed the company’s first-quarter earnings announcement, which revealed troubling insights into its Medicare Advantage business. UnitedHealth Group, based in Minnetonka, Minnesota, revised its adjusted earnings per share forecast for 2025,…
Roche’s $50 Billion Commitment to U.S. Manufacturing and R&D: A Strategic Move Amidst Economic Shifts
Roche, the Basel-based pharmaceutical leader, has committed to investing $50 billion in manufacturing and research infrastructure in the United States over the next five years. This bold move positions Roche alongside various other pharmaceutical companies that are ramping up capital expenditure in anticipation of potential tariffs from the Trump administration. While the administration is diligently…
